ABSTRACT. Although some degree of structural homology has been demonstrated among lactoferrins of different species, other reports suggest that these proteins are immunologically distinct. Human, bovine, and porcine lactoferrins were purified to homogeneity from colostral whey by affinity chromatography on immobilized single-stranded DNA. Evidence for shared antigenic determinants among human, bovine, and porcine lactoferrins was demonstrated by Ouchterlony immunodiffusion and immuno "dot" blots using whole antisera and purified Ig directed against each species of lactoferrin. There was no evidence that human transferrin was recognized by any of the lactoferrin-specific antisera evaluated. The degree of cross-reactivity between the lactoferrins and their trypsin digestion products was also evaluated after SDS-PAGE by immunoblotting. These data demonstrate that human, porcine, and bovine lactoferrins share common antigenic determinants and are likely to be more homologous in tertiary structures than suggested previously. Thus, investigations of human or bovine lactoferrin metabolism in infants that are based upon immunologic methods alone should be conducted cautiously in those cases where the presence of both human and bovine lactoferrin is suspected. Lactoferrin is a 78-kDa metal-binding glycoprotein that belongs to the transferrin gene family (1). Similar to the serum iron transport protein, transfemn, lactofemn contains one high-affinity metal-binding site in each of its two similar lobes. In the case of iron binding, the two high-affinity sites use identical residues as ligands to sequester iron in the presence of bicarbonate ions (2). These sites, as well as additional surface metal binding sites, may also be occupied with several other metal ions (3).
regions of primary sequence homology. Specifically, N-terminal sequence information for porcine lactoferrin (5) indicates homology between human (4), bovine (6), equine (7), monkey (8) , and murine (9) lactofemns. Peptide mapping also has been used to suggest structural homology between porcine and human lactofemns (10). The preliminary structure (x-ray diffraction) for bovine lactofemn (1 1) also demonstrates some degree of structural homology between human and bovine lactofemns.
Although members of the transfemn gene family may be viewed as similar in function and overall structure, considerable differences exist in the surface structure of these proteins (12). Specifically, the question of common antigenicity among the milk lactofemns has not been fully characterized and there is some disagreement on species cross-reactivity. Masson and Heremans (13) used immunodiffusion and reported some cross-reactivity between human and porcine lactofemn, but Kokriakov et al. (10) reported no cross-reactivity between the two species. Wang et a/. (6) reported the absence of cross-reactivity between, human and bovine lact idson and Lonnerdal ( cross-reactivity between monkey and human lactofemn, but di not detect cross-reactiv rins. Rotova el al. (14) porcine and bovine lact fusion studies.
We have recently reported the use of immobilized DNA for the rapid purification of human and porcine lactofenins (5, 15) . This technique has also been used by us to purify bovine lactofemn (Hutchens TW, Magnuson JS, Yip T-T, unpublished data) . We applied the purified lactofemns in investigations of possible structural homologies in which we used more sensitive immunologic methods than have been used previously to address thi: question. In this report, we demonstrate evidence for commor antigenic determinants on human, porcine, and bovine lactoferrins. Whey preparation. Frozen porcine and bovine colostrum wa! thawed at 37°C. and centrifuged at 12 000 x g for 30 min at 4°C The lipid layer was removed and the skim milk proteins de canted. Casein was removed by rennin (Sigma Chemical Co., St Louis, MO) precipitation at 34°C and centrifugation at 12 000 > g for 30 min at 4°C. Human colostrum was thawed at 37°C and the pH adjusted to 4.3. The low pH colostrum was stirred for 1 h at 4°C. then centrifuged at 45 000 rpm in a Beckman TY45 Ti rotor for 45 min at 4°C. The lipid layer was removed and the whey decanted.
MATERIALS AND METHODS

I
A./linit!~ chromatography on single-stranded DNA-agarose. Single-stranded DNA-agarose (lot no. 8NW30 1 ; 1.0 mg DNA/mL gel) was obtained from Bethesda Research Laboratory (Bethesda, MD) and packed into a 2.5-cm inner diameter column to a bed volume of 80 to 100 mL. The column was washed with water, then equilibrated with 20 mM HEPES buffer (pH 8.0) containing 6 M urea, at a flow rate of 30 mL/h. The separation procedure was performed at room temperature (20 to 25°C). Solid urea (to 6 M) was added to the sample before it was applied to the DNA affinity column. The columns were washed (10 x bed volume) with column equilibration buffer. Before gradient elution, the urea was removed with 5-10 column volumes of 20 mM HEPES buffer (pH 8.0). Lactofemn was eluted with stepwise increments of NaCl (0.2 and 0.5 M) in 20 mM HEPES pH 8.0 buffer. Absorbance at 280 nm was measured in each of the collected fractions. After each purification procedure, the DNA-agarose column was washed extensively, first with 2 M NaCl in 20 mM HEPES buffer (pH KO), then with 8 M guanidine-HCI in 20 mM HEPES buffer at pH 8.0. and finally with water. The purity of the isolated lactofemns was evaluated by SDS-PAGE and silverstaining, high-performance reverse-phase (phenyl) chromatography, high-performance ion-exchange (Mono-S) chromatography, and N-terminal amino acid sequence analyses (5, 15, 16) .
Prcparalion of antisera and purljied Ig speciJic for lactoferrin.
Commercial antibodies against human lactofemn were obtained from Dako Corporation (Carpinteria, CA) and Cappel (West Chester, PA). Additional antisera against our purified preparations of human, porcine, and bovine lactofemn were prepared in New Zealand White rabbits by multiple injections (5) of lactoferrin over a 3-mo period, each in Freund's complete adjuvant (Bethyl Laboratories, Montgomery, TX). The antibodies were purified by thiophilic adsorption (17) (18) (19) or by diethylaminoethyl-cellulose chromatography (20) as indicated.
Ouchterlony immzmodilfirsion. Immunologic tests of identity
were performed using Ouchterlony's comparative double-diffusion system (2 1). Six wells. 4 mm in diameter spaced 3 or 6 mm apart, were placed radially around a central well. The gel was composed of 0.9% agarose (Sea Kem, FMC Corporation, Rockland, ME) in PBS, pH 7.4. Twenty pL of various antigen and antibody solutions were applied to the wells as indicated. The purified antibodies used were rabbit antihuman lactoferrin, rabbit antibovine lactofemn, and rabbit antiporcine lactofemn (described above). The absorbance (280 nm) of the purified antibodies ranged from 20 to 80. Human lactofemn standard was obtained from Jackson ImmunoResearch Laboratories, West Grove, PA. Bovine lactoferrin standard was obtained from Sigma. Human serum transferrin was included as a control (Sigma). The absorbance (280 nm) of the antigens ranged from 0. 4-5.0. Antibody was placed into the central well and antigen was placed into the radial wells. The concentration ofthe homologous lactofemn to which the antisera was raised was one tenth that of the heterologous lactofemns or human transfemn. The agarose gels were placed into a humidified chamber at 4°C overnight to allow diffusion. Direct photoreproductions of the gels (with gel placed in the enlarger) were taken after the immunodiffusion gels were soaked overnight in PBS (100 mL). The immunodiffusion gels were oven dried (60°C for 2 to 6 h) before staining (0.125% Coomassie Brilliant Blue G250 in 10% acetic acid, 50% methanol, and 40% water). Gels were destained (10% acetic acid, 50% methanol, 40% water) at room temperature until a clear background was evident.
Immlrno "dot" blot analyses. Immuno dot blots were performed using a microfiltration Bio-Dot apparatus and procedures provided by Bio-Rad (Richmond. CA). Nitrocellulose membranes (Bio-Rad) were used to bind the antigen or control protein of interest (0.015 to 300 pg) and then were blocked with either 1 % (wt/vol) BSA (World Health Organization) or 0.1 % (wt/vol) horse skeletal muscle myoglobin (Sigma). After exposing antigen with primary antibody (whole antiserum diluted 1: I0 or purified antibodies at -1 mg/mL), a horseradish peroxidase-conjugated secondary antibody (goat antirabbit IgG against heavy and light chain, Bio-Rad) was incubated with the membrane according to the manufacturer's instructions. Color development was initiated by adding 4-chloro-I-napthol with hydrogen peroxide in methanol.
Electrophoretic (Western) transfer and immunohlot fing. SDS-PAGE (10-20% total acrylamide, 3% percent of acrylamide represented by bis-acrylamide) was performed under denaturing conditions as described previously (15, 16), except that reducing agents were eliminated during sample preparation. Approximately 5 pg protein were loaded into each well ofthe gel. Western transfer was performed on nitrocellulose membranes (Bio-Rad) at pH 8.3 in 0.025 M Tris, 0.19 M glycine, 20% methanol buffer at 30 V for 16 h at room temperature (22-25°C). After 16 h, the voltage was increased to 60 V for 1 h. The nitrocellulose membranes were blocked for 1.5 h at 37°C with 0.1% myoglobin (horse skeletal muscle, Sigma) in 5 mM Tris-HCI, 0.15 M sodium chloride, pH 8.0. After blocking, the membrane was incubated for 1.5 h at 37°C with either rabbit antihuman, rabbit antiporcine, or rabbit antibovine lactofemn primary antibodies (purified Ig fraction) diluted in 5 mM Tris-HC1 (pH 8.0), 0.15 M NaCI, and 0.05% Tween-20. After incubation with the primary antibody, the membrane was incubated for 1.5 h at 37°C with diluted goat antirabbit IgG antibodies conjugated with horseradish peroxidase (Bio-Rad). Color was developed using 4-chloro-I-napthol with hydrogen peroxide in methanol.
Trypsin digestion of human, bovine, and porcine lacloferrins.
Diferric human lactofemn (Jackson ImmunoResearch), bovine lactoferrin (Morinaga Milk Industry Co., Zama City, Kanagawa, Japan), and purified porcine lactofemns ( I 0 mg/mL) were subjected to mild trypsin digestion in 0.1 M Tris-HCI (pH 8.2) with 0.025 M calcium chloride containing bovine pancreas trypsin (Boehringer Mannheim, Indianapolis, IN) at an enzymelsubstrate ratio of 150. The mixture was incubated at 37°C for 3.5 h, then inactivated with soybean trypsin inhibitor (Sigma). Lactofemn digestions were monitored by SDS-PAGE and highperformance reverse-phase (phenyl) chromatography as described elsewhere (5) .
RESULTS
The possibility of shared antigenic determinants among the purified human, bovine, and porcine lactofemns was investigated first by Ouchterlony immunodiffusion, then by the more sensitive immuno dot blot method, and by Western transfer of SDS-polyacrylamide gels obtained after electrophoresis of both intact and trypsin-digested lactofemns.
Direct visual evidence (unstained gels) for precipitation during Ouchterlony immunodiffusion of unfractionated antisera against the different species of lactofemn was weak, but clear (data not shown). If the antisera were concentrated (3 to 5 times) or if the antibodies were first purified, precipitin lines generated by Ouchterlony immunodiffusion were stronger. The results shown in Figures 1 to 3 demonstrate the type of evidence obtained by Ouchterlony immunodiffusion using antibodies purified by diethylaminoethyl-cellulose chromatography (20). Similar results were obtained with antibodies purified by thiophilic adsorption (17-19) (data not shown). Although the homologous antigenantibody reactions were most obvious. preciptin bands could be observed for every combination of lactofemn and antilactoferrin antibody evaluated (regardless of source). Using the range of antibody and antigen concentrations specified, precipitin lines were detected using wells that were either 3 mm (Figs. 1-3 antisera evaluated, serial dilutions of the nonhomologous antigens allowed for identification of lactoferrin concentrations where only the homologous reactions developed visible precipitin lines. Each of the antihuman lactoferrin antibodies reacted with porcine lactofemn to a greater extent than with bovine lactoferrin. This finding was evident when the antigens were presented at equal concentrations (Fig. I) . In contrast, parallel evaluations of human transferrin at an equivalent concentration revealed no evidence of immunoprecipitation using antibodies directed against lactofemn from any of the species evaluated.
Evidwce of lactoferrin antibody cross-reactivities obtained by Ouchterlony immunodiffusion was confirmed and extended by immuno dot blot analyses. The more sensitive immuno dot blotting technique showed stronger evidence for the presence of human transferrin from Sigma (1c~>l1 5). and a buffer control (~vc~ll 6).
shared antigenic determinants than was seen by Ouchterlony immunodiffusion. Figure 4 demonstrates the positive reaction of human lactofemn, bovine lactofemn, and porcine lactofemn when probed by purified antibodies directed against human lactofemn, bovine lactofemn, and porcine lactofemn. Positive reactions were observed for each combination of antigen and antibody, regardless of source. Results similar to those shown in Figure 4 were obtained with unfractionated. diluted antisera (1:10), probably as a result of the increased sensitivity of this technique relative to Ouchterlony immunodiffusion. No significant reactions were observed with human transfemn as a control protein.
Because lactofemn is predisposed to association with other proteins, including Ig (22), it was important to determine whether nonspecific interactions between the different lactofemns and the various immunologic reagents might give rise to false positive results. This was a particular concern because of the sensitivity of the immuno dot blot technique. Blots with both positive and negative controls were performed routinely (Fig. 4) . Developed blots of the various lactofemn proteins alone (no antibodies), or lactofemn with secondary antibody only (row F; no primary antibody) were negative. Similarly, blots with secondary antibodies alone (~O M J A ; no primary antibody or lactofemn) or primary and secondary antibodies alone (row G; no lactofemn) and buffers alone were negative. Slightly elevated backgrounds were occasionally observed. depending on the membrane type and the individual protein chosen to block nonspecific adsorption phenomena. None of the positive reactions obtained during the course of these investigations could be accounted for by nonspecific interactions.
The degree of lactofemn antibody cross-reactivity was also evaluated for each species of lactofemn by SDS-PAGE and immunoblotting. The immunoblotting profiles shown in Figure  5 confirm the evidence for cross-reactivity obtained by Ouchterlony immunodiffusion and immuno dot blotting under nondenaturing conditions. Under denaturing (but nonreducing) conditions, antihuman lactofemn antibodies cross-reacted with porcine lactofemn to a greater extent than with bovine lactofemn. Antibovine lactofemn antibodies, however, cross-reacted more strongly with porcine lactofemn than with human lactofemn. Antibodies directed against porcine lactofemn showed the same, degree of cross-reactivity toward human and bovine lactofemns. 
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JhLF hLF pLF MbLF ShTF Fig. 4 . lmmuno dot blots. Purified antigens are as indicated: human ctofcrrin. 11LFand JI~LI.'(Jackson ImmunoResearch): bovine lactofern. .\lhl.I.'(Morinaga): porcine lactoferrin. p1.F: human serum transfern. SIITI.' (Sigma). Antigens without a specified source were those -epared by us as described in Methods. Each evaluation shown was :rformed in duplicate. R~I I : Y B-E represent serial dilutions (3.75-0.24 :) of the specified antigens. Control blots with secondary antibody only 011, ..I). antigen (3.75 ~g ) and secondary antibody only (rob1 I.'). and imary and secondary antibody only ( r o~~ G) were indistinguishable om thc unrcacted nitrocellulose. Putic.1 .-I was blotted with purified tih human lactoferrin antibodies (Dako). I' unc,l U was blotted with ~rified antibovine lactoferrin antibodies (Bethyl). Punc'l C was blotted ~t h purified antiporcine lactoferrin antibodies (Bethyl). The results own are representative of >20 similar comparisons. Fig. 5 . Westcrn transfer and immunohlots of lactoferrins analyzed by SDS-PAGE. Samplc denaturation was pcrformed under nonreducing conditions. I'(1ni~1 : 1 was blotted with purified antihuman lactofemn antibodies (Dako). Lanes indicated are: I, human lactofemn (Jackson ImmunoResearch). 2. human lactoferrin (purified by single-stranded DNA). 3. porcine lactoferrin (purified by single-stranded DNA). 4. bovine lactofcrrin (purified by single-stranded DNA). 5, bovine lactoferrin (Sigma). and 6. human transferrin (Sigma). Punrl B was blotted with purified antibovine lactoferrin antibodies (Bethyl). Lanes indicated are: I, human lactoferrin (Jackson). 2. human lactoferrin (single-stranded DNA). 3. porcine lactoferrin (single-stranded DNA), 4, bovine lactoferrin (single-stranded DNA). 5. bovine lactoferrin (Sigma). and 6, human transferrin (Sigma). Prlncl C was blotted with purified antiporcine lactoferrin antibodies (Bethyl). Lanes indicated are: I. human lactofemn (Jackson). 2, human lactoferrin (single-stranded DNA). 3. porcine lactofcrrin (single-stranded DNA), 4. bovine lactoferrins (single-stranded DNA). 5. bovine lactoferrin (Sigma). and 6. human transfemn (Sigma). Western blots of SDS-polyacrylamide gels have been used with increasing frequency to evaluate the metabolic fate of ingested human and bovine lactofemns. Thus. the trypsin digestion products from human. porcine. and bovine lactofemns were evaluated by SDS-PAGE and Western immunoblotting. This method also enabled the identification of specific regions (peptides) of common structure and antigenicity. The results shown in Figure  6 reveal that the individual trypsin digestion products (i.e. peptides) from each given species of lactofemn varied distinctly in antigenicity. Peptides with and without shared antigenic determinants were observed regardless of whether the trypsin digestion products were denatured in the presence or absence of reducing reagent. Although the lactoferrins varied in their tryptic digestion patterns (under both reducing and nonreducing conditions), common digest products could be identified that were responsible for shared as well as unique antigenicity. DISCUSSION 
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The protein now referred to as lactofemn was first discovered in 1939 and partially purified from bovine milk by Sorensen and Sorensen (23) . It has since been identified in the colostrum and milk of several other species ( I , 5, 7-10, 13. 14, 24, 25) . Lactofemn is also stored in neutrophil granules and is a major protein component of various mucosal secretions (1). In addition to iron binding, a number of other biologically important functions have been ascribed to lactofemn (I). Its primary function and use are uncertain and may vary on the basis of location, metal ion availability, and posttranslational modification.
Immunologic reagents are used extensively to monitor the presence and concentrations of lactofemn in biologic fluids. In the field of infant nutrition and preterm infant care, the biology of lactofemn has been a primary focus of attention (1 6, 26-32) . Within this context, it is particularly important to establish the degree to which bovine and human lactofemns do or do not share immunologic determinants, because the differential function and metabolic fate of ingested lactofemns is unknown. Several investigations have been directed toward understanding the relative nutritional and immunologic contributions (i.e. use) of lactofemn. Preterm infants fed human milk have been reported to have increased levels of both fecal and urinary outputs of lactofemn (26) (27) (28) . Whether the urinary lactofemn is exclusively of dietary origin is not yet known (16). If infants were fed cow milk formula along with human milk, or infant formula with added bovine lactofemn, problems with the separate immunologic detection of human and/or bovine lactofemn (or their fragments) may have been or may be underestimated. Questions certainly arise in regard to the immunologic detection and quantitation of human lactofemn in clinical specimens obtained from infants fed cow milk formulas alone or formulas based on cow milk that has been fortified with human milk fractions. Similar complications may also be encountered during the experimental evaluation of transgenic cows and pigs designed to produce human lactofemn. These concerns are particularly valid when sensitive methods of detection are used.
Despite previous reports arguing the absence of cross-reactivity between lactofemns of different species. our data have demonstrated unequivocally that cross-reactivity occurs between human, porcine, and bovine lactofemn. The degree of cross-reactivity varies between species. The ability to detect cross-reactivity. if desired, varies with antibody titer, purity. and method of detection. The degree of antibody cross-reactivity will have to be determined separately for each antiserum (or MAb), sample type, and method of detection (28). Increased caution is particularly necessary in the interpretation of either qualitative or quantitative immunologic methods of evaluating human and bovine lactofemn digestion products.
The next stage of this investigation will be to determine the precise location of shared antigenic determinants on the surface of the different lactofemns. Speculation is inappropriate at this time regarding the biologic significance or possible functional relationships (E.R. receptor-binding or metal-binding domains) of lactofemn structures with preserved antigenic determinants.
